Fred Alger Management, LLC Amicus Therapeutics, Inc. Transaction History

Fred Alger Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$10.96 - $14.4 $767,200 - $1.01 Million	-70,000 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$10.04 - $13.92 $200,799 - $278,400	20,000 Added 40.0%	70,000 $952,000
Q4 2018 Feb 14, 2019	SELL	$8.38 - $13.44 $486,040 - $779,520	-58,000 Reduced 53.7%	50,000 $479,000
Q3 2018 Nov 14, 2018	BUY	$11.6 - $16.54 $34,800 - $49,620	3,000 Added 2.86%	108,000 $1.31 Million
Q1 2018 May 10, 2018	SELL	$13.76 - $17.12 $41,280 - $51,360	-3,000 Reduced 2.78%	105,000 $1.58 Million
Q4 2017 Feb 14, 2018	SELL	$12.51 - $16.24 $25,020 - $32,479	-2,000 Reduced 1.82%	108,000 $1.55 Million
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $1.29 Million - $1.74 Million	110,000	110,000 $1.66 Million

311

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.